BBOX1 and psoriasis: Our findings revealed that CD147 has a critical role in metabolic reprogramming through the α-KG–H3K9me3–BBOX1 axis in the pathogenesis of psoriasis, indicating that epidermal CD147 is a potentially promising target molecule for psoriasis treatment (Fig. 6D).